Key result
Implantable cardiac monitors (Reveal XT and LINQ) were compared to assess temporal trends in patient selection, arrhythmia detection, and clinical outcomes in routine practice.
Why the study?
Does the LINQ implantable cardiac monitor improve arrhythmia detection and clinical outcomes compared to the Reveal XT in patients with unexplained symptoms?
Does the LINQ implantable cardiac monitor improve arrhythmia detection and clinical outcomes compared to the Reveal XT in patients with unexplained symptoms?
This study compares patient selection, arrhythmia detection, and clinical outcomes between Reveal XT and LINQ implantable cardiac monitors in routine clinical practice.
Trends in implantable cardiac monitor selection and detection are hypothesis-generating; randomized trials needed to compare devices.
Implantable cardiac monitors (ICMs) are useful for long-term arrhythmia monitoring in patients with unexplained symptoms. Temporal trends in the use of ICMs in routine clinical practice, a...
No takes yet. Share an insight, caveat, or question.
Sethi et al. (2017) studied this question. Implantable cardiac monitors (Reveal XT and LINQ) were compared to assess temporal trends in patient selection, arrhythmia detection, and clinical outcomes in routine practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: